Abstract
Sisters with a mild variant of non-ketotic hyperglycinaemia resulting from a defect in the T-protein of the glycine cleavage system had different clinical outcomes. The older sister was ascertained at 6 months of age because of mental retardation. She received only brief treatment with sodium benzoate from 11–15 months and at 15 years of age is profoundly retarded and has epilepsy. The younger sister was diagnosed 36h after birth, was treated with strychnine, sodium benzoate and arginine from the neonatal period and at 27 months of age is only moderately retarded and free of seizures. The possible role of strychnine in the improved outcome is discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- NKH:
-
non-ketotic hyperglycinaemia
- CSF:
-
cerebrospinal fluid
References
Ando T, Nyhan WL, Bicknell J, Harris R, Stern J (1978) Nonketotic hyperglycinaemia in a family with an unusual phenotype. J Inherited Metab Dis 1:79–83
Applegarth DA, Edelsten AD, Wong LTK, Morrison BJ (1979) Observed range of assay values for plasma and cerebrospinal fluid amino acid levels in infants and children aged 3 months to 10 years. Clin Biochem 12:173–178
Arneson D, Chien LT, Chance P, Wilroy RS (1979) Strychnine therapy in non-ketotic hyperglycinemia. Pediatrics 63:369–373
Bank WJ, Morrow G (1972) A familial spinal cord disorder with hyperglycinaemia. Arch Neurol 27:136–144
Carson NAJ (1982) Non-ketotic hyperglycinaemia — a review of 70 patients. J Inherited Metab Dis 5 [Suppl 2]:126–128
Cole EC, Meek DC (1985) Juvenile non-ketotic hyperglycinaemia (NKH) in 3 siblings. J Inherited Metab Dis 8[Suppl 2]:123–124
Degroot CJ, Troelstra HA, Hommes FA (1970) Non-ketotic hyperglycinaemia: an in vitro study of the glycine-serine conversion in liver of three patients and the effect of dietary methionine. Pediatr Res 4:238–243
Dickinson JC, Hamilton PB (1966) The free amino acids of human spinal fluid determined by ion exchange chromatography. J Neurochem 13:1179–1187
Flannery DB, Pellock J, Bousounis D, Hunt P, Nance C, Wolf B (1983) Non-ketotic hyperglycinemia in two retarded adults: a mild form of infantile non-ketotic hyperglycinemia. Neurology 33: 1064–1066
Frazier DM, Summer GK, Chamberlin HR (1978) Hyperglycinuria and hyperglycinemia in two siblings with mild developmental delays. Am J Dis Child 132:777–781
Gitzelmann R, Steinmann B, Otten A, Dumermuth G, Herdan M, Reubi JC, Cuenod M (1977) Non-ketotic hyperglycinemia treated with strychine, a glycine receptor antagonist. Helv Paediatr Acta 32:517–525
Hayasaka K, Tada K, Kikuchi G, Winter S, Nyhan WL (1983) Non-ketotic hyperglycinemia: two patients with primary defects of P-protein and T-protein, respectively, in the glycine cleavage system. Pediatr Res 17:967–975
Holmgren G, Blomquist K (1977) Non-ketotic hyperglycinemia in two siblings with mild psycho-neurological symptoms. Neuropaediatrie 8:67–72
Krieger I, Winbaum ES, Eisenbrey AB (1977) Cerebrospinal fluid glycine in non-ketotic hyperglycinemia. Effect of treatment with sodium benzoate and a ventricular shunt. Metabolism 26:517
Lefauconnier JM, Trouve R (1983) Developmental changes in the pattern of amino acid transport at the blood-brain barrier in rats. Dev Brain Res 6:175–182
MacDermot KD, Nelson W, Soutter V, Towne D, Schulman JD (1981) Glycine and benzoate conjugation and glycine acyl transferase activity in the developing and adult rat: possible relationship to non-ketotic hyperglycinemia. Dev Pharmacol Ther 3:150–159
Nyhan WL (1983) In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds) The metabolic basis of inherited disease, (5th edn.) McGraw-Hill, New York, pp 561–569
Okken A, Degroot CJ, Hommes FA (1970) Non-ketotic hyperglycinemia. J Pediatr 77:164–165
Parvey Ph, Huang Y, Kamoun P (1979) Age related reference values for urinary free amino acids: a simple method of evaluation. J Clin Chem Clin Biochem 17:205–210
Perry TL, Hansen S, Kennedy J (1975) CSF amino acids and plasma-CSF amino acid ratios in adults. J Neurochem 24:587–589
Pohlandt F (1978) Plasma amino acid concentrations in newborn infants breast-fed ad libitum. J Pediatr 92:614–616
Steiman GS, Yudkoff M, Berman PH, Blazer-Yost B, Segal S (1979) Late-onset non-ketotic hyperglycinemia and spinocerebellar degeneration. J Pediatr 94:907–911
Steinmann B, Gitzelmann R (1979) Strychnine treatment attempted in newborn twins with severe non-ketotic hyperglycinemia. Helv Paediatr Acta 34:589–599
Trauner DA, Page T, Greco C, Sweetman L, Kulovich S, Nyhan WL (1981) Progressive neurodegenerative disorder in a patient with non-ketotic hyperglycinemia. J Pediatr 98:272–277
Von Wendt L, Simila S, Saukkonen A-L, Koivisto M (1980) Failure of strychnine therapy during the neonatal period in three Finnish children with non-ketotic hyperglycinemia. Pediatrics 65: 1166–1169
Von Wendt L, Simila S, Saukkonen A-L, Koivisto M, Kouvalainen K (1981) Prenatal brain damage in non-ketotic hyperglycinemia. Am J Dis Child 135:1072
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Haan, E.A., Kirby, D.M., Tada, K. et al. Difficulties in assessing the effect of strychnine on the outcome of non-ketotic hyperglycinaemia. Observations on sisters with a mild T-protein defect. Eur J Pediatr 145, 267–270 (1986). https://doi.org/10.1007/BF00439398
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00439398